review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1097/MOT.0B013E328348B44C |
P698 | PubMed publication ID | 21666472 |
P50 | author | Christopher J Watson | Q60057362 |
P2093 | author name string | Roy Calne | |
P433 | issue | 4 | |
P304 | page(s) | 353-358 | |
P577 | publication date | 2011-08-01 | |
P1433 | published in | Current opinion in organ transplantation | Q26842426 |
P1476 | title | Some observations on prope tolerance | |
P478 | volume | 16 |
Q48288606 | "It can't be done". |
Q42535946 | A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award |
Q36818003 | Alemtuzumab induction in pediatric kidney transplantation. |
Q42234521 | BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION. |
Q38080021 | Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects |
Q39363717 | Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction. |
Q56886145 | Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells: A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade |
Q38224758 | Lung transplantation: chronic allograft dysfunction and establishing immune tolerance |
Q27318199 | Prospects for therapeutic tolerance in humans |
Q43563597 | Regulatory T cells and transplantation tolerance. |
Q45109894 | Taking the rap: multiple effects of blocking mammalian target of rapamycin |
Search more.